Namita Gill, MD
Nephrology · Bremerton, WANPI 1467640318
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $980 of the $1,386 with a category attached, or 70.7%. Vantive US Healthcare LLC accounts for 90.4% of it on its own, with 2 other manufacturers making up the rest.
Across 13 payments — averaging $106.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vantive US Healthcare LLC$1K
- Bayer$114
- AbbVie$19
What the payments were for
- Travel & lodging$98071%
- Food & beverage$40629%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vantive US Healthcare LLC | 11 | $1,253 |
| Bayer | 1 | $114 |
| AbbVie | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Renal - Chronic$1,101
- Kerendia$114
How this compares
$1,386 in reported general payments places this provider in the 80th percentile of 237 nephrology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 12 | $60,790 |
| JardianceEmpagliflozin | 43 | $47,867 |
| AuryxiaFerric Citrate | 15 | $36,436 |
| FarxigaDapagliflozin Propanediol | 26 | $29,728 |
| Sevelamer Carbonate | 72 | $17,584 |
| ClinolipidFat Emulsion/Olive/Soy/Phospho | 33 | $8,372 |
| Cinacalcet Hcl | 19 | $8,203 |
| ProsolParenteral Amino Acid 20% No.1 | 51 | $7,065 |
| Potassium Citrate ErPotassium Citrate | 51 | $5,275 |
| Calcium Acetate | 55 | $4,495 |
| RetacritEpoetin Alfa-Epbx | 18 | $4,233 |
| Calcitriol | 205 | $3,383 |
| Allopurinol | 173 | $2,253 |
| Hydralazine Hcl | 108 | $2,245 |
| Carvedilol | 170 | $2,208 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Bremerton
- Dmitri VasinBremerton$215K
- Kathrine TuttleSpokane$421K
- Osama AmroSeattle$395K
- Ian de BoerSeattle$117K
- Nicolae LecaSeattle$101K
- Syeda AhmadSeattle$68K
- Charles MinnTacoma$67K
- Saw Hnin MuShoreline$25K
- Mahesh DangalVancouver$20K
- Stuart ShanklandSeattle$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.